chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Warm to the touch circle at the site of injection; Itchy circle at the site of injection; Red circle at the site of injection; Sore circle at the site of injection; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection), VACCINATION SITE PRURITUS (Itchy circle at the site of injection), VACCINATION SITE ERYTHEMA (Red circle at the site of injection) and VACCINATION SITE PAIN (Sore circle at the site of injection) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection), VACCINATION SITE PRURITUS (Itchy circle at the site of injection), VACCINATION SITE ERYTHEMA (Red circle at the site of injection) and VACCINATION SITE PAIN (Sore circle at the site of injection). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Warm to the touch circle at the site of injection), VACCINATION SITE PRURITUS (Itchy circle at the site of injection), VACCINATION SITE ERYTHEMA (Red circle at the site of injection) and VACCINATION SITE PAIN (Sore circle at the site of injection) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.
one of my friend told me that he had a similar thing happen to him where he felt that some of the vaccine was running down his arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) for 1 day as unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INJECTION SITE EXTRAVASATION (non-serious), outcome "unknown", described as "one of my friend told me that he had a similar thing happen to him where he felt that some of the vaccine was running down his arm". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I received the 2nd dose of my Pfizer COVID-19 vaccine on 01/25/2021 at ~7:30am, at around 2:00pm I noticed I had generalized fatigue, a general sense of feeling cold, and the muscles in the back of my neck were sore, which was causing a tension-like headache. The fatigue gradually increased throughout the day. I attempted to go to bed around 11:00pm and I was so cold my entire body was shivering to a point where my whole body was shaking. I also began noticing muscle cramps throughout my body as well, primarily located in my calves. Eventually fell asleep around 2:00am (symptoms were preventing me from falling asleep), when waking up noticed the symptoms had resolved.
This spontaneous report was received from a physician and from a support services director via company representatives and refers to a patient of an unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 21-JUN-2016, the patient was vaccinated with a dose of an improperly stored GARDASIL (strength: 0.5 ml) lot # L020162 and expiration date: 23-JUL-2017 (dose, anatomical location and route of administration were not reported). No adverse effects were reported. The dose of the vaccine was exposed to a temperature excursion (date unspecified): lasting for 120 hours, with the highest recorded temperature of 53 degrees Fahrenheit (11.66 degrees Celsius). The vaccine was stored in a refrigerator. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
6 months after second dose of COVID vaccine tested positive for COVID; 6 months after second dose of COVID vaccine tested positive for COVID; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An 8-year-old patient received BNT162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "6 months after second dose of COVID vaccine tested positive for COVID". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: positive.  Clinical course: 8-year-old, 6 months after second dose of COVID vaccine tested positive for COVID. Name of Product: COVID-19 vaccine. Event took place after use of product.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Normal pregnancy other than anemia of pregnancy, EDD 02/18/21. Woke around 0030 with rigors, temp 103.5F, muscle aches, joint pain. Fever resolved with 1000mg Tylenol and hydration. Fevers continued with Tmax 102.5 for next 24 hours.  Muscle aches, joint pain, headache, and fatigue persisted for about 36 hours total.
I received my first covid vaccination on April 14th and my second on May 12th 2021, both at 1030 in the morning. I had the same adverse effects after both shots. After receiving the shot I felt fine throughout the rest of the day. I work second shift and accomplished my daily routine and went to work at my normally scheduled time of 2:30 in the afternoon. Around lunch time 7:30-8:00 I started to feel very drained of energy, extemely tired. When I closed my eyelids, they felt hot and I started to feel feverish. I am the supervisor of my work center and my work leader was off (first dose - 14 Apr) so I could not just go home and leave the work center without supervision, so I stayed at work gradually feeling worse as the night progressed. When I got home  around 12:30 I had a fever and chills. It seemed I could not get warm enough, especially my hands and feet.  My chills were so bad I had uncontrollable shivering, and eventually after burying myself in blankets the fever made me feel warm and the uncontollable shivering stopped. I also experienced a headache throughout the night. I took acetaminophen and the next day I felt better, but it took about three days for the negative side effects to completely disappear.
immediate ( less than 5 mins) Swelling- tongue & Throat,  tachycardia, hi B/P.       treatment - 50 mg Benadryl liquid ( orally -brought by patient) administered by patient w/ Dr approval,. Then the facility gave me 2 -10 mg Pepcid  tablets and 1 Decadorn hip injection 2.5 ml     I had to stay about an hour. Swelling subsided, pulse and B/P did come down to an acceptable level. I was discharged and given a prescription for 2 EpiPen's.  I continued to have some swelling issues until about 6 pm.  Next day ( today) severe headache and dizziness. I am taking  4oo mg Motrin-  has not totally relieved headache or dizziness.
12:30 AM 10/10/03 patient woke with fever 103 F, shaking chills, and severe myalgia especially of vaccine site but also other major muscle groups.  7:00 AM 10/10/03 patient attempted to stand, developed acute onset pounding headache, dizziness,nausea and tinnitus - unable to walk or stand due to symptoms 7:45 AM 10/10/03 patient obtained glass of water and 600 mg ibuprofen 9:00 AM 10/10/03 fever down to 99.7 F, patient feeling much better. Still sore and dizzy, but able to function.
pain on touch; Pain then moved down spine of back; appearing as having a shingles outbreak; had pinpoint pain/Pain upon movement; area on back began itching / itching near lumbar region; swelling; pain when touching area on left side underneath shoulder; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (the patient experienced in 2010).   On an unknown date, the patient received the 1st dose of Shingrix. In July 2020, 36 hrs after receiving Shingrix, the patient experienced shingles, pain, pruritus, swelling, shoulder pain and back pain. On an unknown date, the patient experienced tenderness. On an unknown date, the outcome of the shingles, swelling, shoulder pain, back pain and tenderness were unknown and the outcome of the pain and pruritus were not recovered/not resolved.   It was unknown if the reporter considered the shingles, pain, pruritus, swelling, shoulder pain, back pain and tenderness to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The patient receiving 1st dose Shingrix approximately 1 to 2 weeks ago in left arm, and approximately 36 to 48 hours later consumer reported an area on back began itching. The patient looked in mirror but could not see anything and at that point only had pinpoint pain. The reporter stated swelling and then pain when touching area on left side underneath shoulder blade that lasted for one week. Pain then moved down spine of back near trunk on left side.  At the time of reporting, pain and itching now reportedly near lumbar region. The reporter appearing as having a shingles outbreak but not as bad as first case of shingles in 2010 prior to Shingrix vaccine.  The reporter consent to follow up.
pt recv vax OCT96 & 26NOV96 pt devel cough, congestion, sl h/a, exhaustion & required med tx;pt has not yet recovered;
I had cough, sinus pressure, mucus, phlegm. I went to the doctor on 02/21/2023 where they performed a lung x-ray to ensure it wasn't pneumonia and bloodwork; later, I was told I had norovirus. It lasted for about 4 weeks. I was prescribed codeine cough syrup for recovery. As of now, I'm doing well and much better.
after the first vaccine like a little bit more itchy; it hurt little bit more when I got it; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43-year-old female patient received BNT162b2 (BNT162B2), on 30Mar2021 as dose 1, single (Lot number: ER8734) at the age of 43 years for covid-19 immunisation. The patient's relevant medical history included: "Anxiety" (unspecified if ongoing); "Acid reflux" (unspecified if ongoing), notes: Acid reflux Consumer stated, "I have acid reflux but I don't take anything for it. Concomitant medication(s) included: LEXAPRO. The following information was reported: PRURITUS (non-serious), outcome "not recovered", described as "after the first vaccine like a little bit more itchy"; PAIN (non-serious), outcome "not recovered", described as "it hurt little bit more when I got it". The events "after the first vaccine like a little bit more itchy" and "it hurt little bit more when i got it" required physician office visit. Therapeutic measures were not taken as a result of pruritus, pain.
LOCALIZED SWELLING, REDNESS ABOUT THE SIZE OF A HALF DOLLAR. WARM TO THE TOUCH
No vaccine related effects noted. Client given Novartis, preservative-free vaccine, cleared for 4 y/o and older.
nausea; chills; arm is swollen; This is a spontaneous report from a contactable consumer (patient). A 28-year-old female patient second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on 11Jan2021 11:30 in the left deltoid at single dose for COVID-19 immunization, administered in the hospital. Medical history included birth control. The patient's concomitant medications were not reported. The patient received first dose of BNT162B2 on 23Dec2020 administered in the left deltoid. Her arm was swollen as she noticed this morning (12Jan2021) when she woke up, about 07:00. She placed ice on it and the swelling had gone down a little. Nausea and chills started around 09:30 this morning. The outcome of the event arm was swollen was recovering; while outcome of the events nausea and chills was not recovered.  Information on batch/lot number was requested.
She wanted to know if she can take over-the-counter medications for her symptoms. (like Tamiflu and cough medications); She wanted to know if she can take over-the-counter medications for her symptoms. (like Tamiflu and cough medications); This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection, Batch/Lot number was not reported, Expiry date was not reported), dose 1 via an unspecified route of administration on an unspecified date as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced she wanted to know if she can take over-the-counter medications for her symptoms (like tamiflu and cough medications). The clinical outcome of the events was unknown.  The lot number for the vaccine was not provided and will be requested during follow up.
Three minutes post vaccination child fainted. This occurred in the next room, where patients are monitored. Possible seizure. We know he hit his head face forward
Child recieced H1N1 vaccination while at school. Developed Rash type welts on face approx. 1 hour after vaccination.within 1 hour after that the rash faded to a flushed face. Flushing disappeared in several hours. Child returned to school the next day with no symptoms. Parents aware of possible allergic type reaction to report to family MD
Information has been received from a physician via Company representative concerning to a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 19-AUG-2015, the patient was vaccinated with an improperly stored dose of GARDASIL "10x1 sdv" (Lot No. K001631, exp. 24-FEB-2017) (dose and site not reported). On an unspecified dates, the GARDASIL vaccine had six temperature excursions: 80, 336, 416, 24, 168 and 1172 hours respectively. The lowest recorded temperature were 30 (-1.111111111 Celsius degrees) and -3 (-3 Celsius degrees). The highest recorded temperatures were 49 (9.444444444 Celsius degrees), 47 (8.333333333 Celsius degrees), 59 (15 Celsius degrees) and 48 (8.888888889 Celsius degrees). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
having shingles; sick; four years AFTER the  first vaccine. when the second vaccine became available I did; This case was reported by a consumer via (media and described the occurrence of shingles in a elderly patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included surgery (have had surgeries) and illness (have had usual illness).   On an unknown date, the patient received the 1st dose of Shingles vaccine and the 2nd dose of Shingles vaccine. On an unknown date, 4 years after receiving Shingles vaccine and not applicable after receiving Shingles vaccine, the patient experienced shingles, sickness and drug dose administration interval too long. On an unknown date, the outcome of the shingles, sickness and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the shingles and sickness to be related to Shingles vaccine.  Additional details provided were as follows: The reporter was the patient himself/herself. Age at vaccination was not reported but the patient was nearly 80 years old. The patient have had all the usual illness, surgeries, and problems of life The patient received a dose of Shingles vaccine and it made him/her sickest ever he/she would have been.  The patient received 2nd dose later than the recommended interval after four years after the first vaccine which led to lengthening of vaccination schedule. The patient stated that when the second vaccine became available, his/her insurance would not pay for it, so he/she did gladly. Follow-up would not be possible as no contact details were available.
She had the same stuff on her feet and her hands/blisters and rashes; She had the same stuff on her feet and her hands/blisters and rashes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID.  A 76-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 76 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTUERER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTUERER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3; MANUFACTUERER UNKNOWN), for COVID-19 immunization. The following information was reported: BLISTER (non-serious), RASH (non-serious), outcome "unknown" and all described as "She had the same stuff on her feet and her hands/blisters and rashes".  Additional information: the patient got her 4th vaccination and she had the same stuff on her feet and her hands as the reporter does (blisters and rashes) and she never had anything on her skin.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swelling and redness at injection site on 3/3. Child taken to local clinic dx'd cellulitis.
Swollen Tongue; A spontaneous report was received from a consumer concerning a 63-years-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273), and who experienced swollen tongue.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.   On 31 Dec 2020, approximately 3 days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On 02 Jan 2021, patient experienced swollen tongue. Treatment for the event included Benadryl.  Action taken with mRNA-1273 in response to the event was not provided.   The outcome of the event, swollen tongue was not reported.; Reporter's Comments: This case concerns a 63-years old female patient with unknown medical history subject, who experienced a serious unexpected event of swollen tongue. The event occurred three days after  first dose of mRNA-1273 vaccine. Treatment for the event included Benadryl.; however, outcome wasn't reported. The event was assessed as possibly related due to temporal association, however additional information has been requested.
Started out with medicine taste in mouth then burning then swelling of tissues in the mouth, tongue swelling,voice changed, difficulty swallowing, could only breath thru my nose. Went to emergency room blood pressue went to 223/117 gave me iv's with several kinds of medicine put me on heart monitor and blood pressue monitor. After several hours in the emergency room symptoms started to subside gave me blood pressue medicine. Followed up with prednisone, and Zantac. Blood pressue still elevated.  11/3/2009 records from ED visit 10/6/2009.Dc Dx Angioedema, high blood pressure  Patient with c/o's trouble swallowing, lips and tongue swelling. patient became hypertensive and elevated HR.  Tx'd with Epinephrine, IV Benadryl, Solu Medrol and Pepcid and po Clonidine, placed on telemetry. .
feeling nauseous; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection; Batch/Lot number was not reported), dose 1 via an unspecified route of administration on as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 07Sep2021 caller had the first dose of the Pfizer COVID-19 vaccine in August and she is due for the second shot on Friday. She said that she had been feeling pretty good but yesterday and today, she is feeling nauseous. She said that that is her only symptom. She wanted to know if she should be concerned having the adverse event weeks after getting the vaccine. She wanted to know if something bad is starting to happen to her. The outcome of the event was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Rt arm was red, hot, swollen night of vaccination. Remained red, hot, swollen & painful for 2 weeks.  Redness, heat & swelling gone after 2 weeks but remains painful to move or use R arm to present date.
A sales representative reported that a 30 month old received an injection of Prevnar. On 3/10/00, following the vax, the pt developed a body rash from "head to toe." On the following day, the pt developed an injection site reaction, characterized as a hard, hot knot. Follow-up information received from the physician on 4/11/00 indicated the pt had received one previous dose of Prevnar. The pt recovered.
Information has been received from a consumer concerning his 16 month old son with no pertinent medical history and no known drug allergies/drug reactions who on an unspecified date was vaccinated with a dose of ATTENUVAX. There was no concomitant medication reported. It was reported that "same day of the vaccination" the patient developed fever of 103 degrees F and rash on his arm and chest. The patient did not seek medical attention. It was reported that the patient recovered 2 or 3 days after the vaccination. The reporter also indicated that the patient developed an adverse experience after another vaccine WAES # 0905USA01701. Additional information has been requested.
Member received wrong dose of covid vaccine booster. Vial was diluted by staff, should not have been diluted
I took the meningococcal ACWY because I was kicked out of school due to government laws were I could not attend if I didn't have it, after I took it my spine started to feel more sore. the next day during school my spine had just started feeling like someone had been stabbing my back multiple times. I cannot do any normal activity without feeling excruciating pain. I cannot even put on my socks without feeling like someone is stabbing my back. It doesn't matter if I am standing or sitting down, I still feel excruciating pain. Whenever I have to bend over it feels as if my legs lose all their power and I'm afraid that I might fall and further ingire myself.